UI Health/University of Illinois Chicago
Chicago, Illinois, 60612, United States
Location status: Recruiting
NCT Number: NCT06754280
RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.
Interested in participating?
Request Info35 year–80 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60612, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
RESET-CKD is a 12-week intervention that consists of four major components to support decreasing sedentary behavior: (1) health coaching, (2) feedback charts on sedentary behavior, (3) a workbook, and (4) reminders and cues.
CKD-related education
Time frame: Baseline to week 12
Change in activPAL-measured sedentary time
Time frame: Baseline to week 12
Change in self-reported sedentary time
Time frame: Baseline to week 12
Change in health-related quality of life measured via the KDQOL
Contact information is provided by the study sponsor or research team.
University of Illinois at Chicago
Other
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease: RESET-CKD
Acronym: RESET-CKD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06694558
Autoimmune Diseases, Chronic Disease
Cleveland, Ohio, United States
View Trial DetailsNCT06906640
Chronic Disease, Chronic Kidney Disease(CKD)
Birmingham, Alabama, United States
View Trial DetailsNCT06906627
Chronic Disease, Chronic Kidney Disease(CKD)
Birmingham, Alabama, United States
View Trial DetailsNCT07083557
Atherosclerotic Disease, Atrophy
Columbia, Missouri, United States
View Trial Details